In human lung adenocarcinoma, NEDD9 expression is upregulated upon loss of the tumor suppressor serine/threonine kinase 11 (STK11, also called LKB1), and its expression is downregulation upon re-expression of LKB1 (17). Here, NEDD9 is linked to lung adenocarcinoma.